North West Coast

Tuesday 2 April 2019
Mercure Haydock

innovation agency smaller

AGENDA

09:00 AM

Registration & Refreshments

09:25 AM

Event App Overview Karl Hamer

09:30 AM

Welcome and Overview
Dr Philip Jennings

09:40 AM

Preventing AF-related strokes : A call to action Professor Tony Rudd

10:00 AM

National AHSN Programme Faye Edwards

We will explore the scale of opportunities and challenges ahead. Look at national initiatives and their impact to-date.

10:15 AM

Stroke Prevention Aidan Kirkpatrick and Margarita Perez-Casal

10:35 AM

How a local Academic Health Science Network supports AF and Stroke Prevention Dr Julia Reynolds

10:50 AM

BHF Patient Video

10:55 AM

Patient Story: The patient's perspective Julian Clarke

11:00 AM

Panel Q&A Session 

11:20 AM

Morning Refreshments

11:40 PM

Roundtable Discussions (6 tables - choose 3) - 20 minutes each session

  • AF Ambassadors – Debbie Parkinson
  • Quality improvement and AF in GP practices – a GPs perspective – Dr Lucy Astle
  • Quality Improvement – A CCG-wide QI initiative– Dr Quincy Chuka
  • Evaluating a Self-Monitoring of Warfarin intervention – Dr Emma Bray
  • Quality Improvement in Primary Care - experience of rolling out a programme at scale – Dr Michelle Coleiro
  • Virtual Clinics – Helen Williams
12:40 PM

Introduction to Roundtable Feedback Session
Dr Philip Jennings

13:05 PM

Lunch

13:50 PM

Feedback from Roundtable Groups - Actions

14:10 PM

How RightCare supports the system - Finding AF Data Nina Russell

14:40 PM

Creating a Culture for Improvement and Innovation Jen Kohan & Karla Rimaitis

15:10 PM

Q&A Session and Meeting Close Dr Philip Jennings

15:25 PM

Afternoon Refreshments

SPEAKERS

Dr Phil Jennings is Medical Director at the Innovation Agency and a practising GP.  He leads the patient safety team which deliver a number of national programmes in primary and secondary care incorporating both physical and mental health. Previously Phil was the Primary Care Lead for the Cheshire and Merseyside Cardiac Network and helped to develop the Wirral Intermediate Cardiac Clinic. He joined the management team of Wirral PCT and subsequently became Chairman of NHS Wirral Clinical Commissioning Group, where he led the organisation through its development and authorisation. Prior to joining the Innovation Agency Phil worked in the NHSE Cheshire and Merseyside as Deputy Medical Director.

 

 

 

Tony Rudd is Professor of Stroke Medicine at Kings College London and the National Clinical Director for Stroke for NHS England. He runs the stroke programme producing national stroke guidelines and the national audit (SSNAP). His research interests are stroke rehabilitation, organisation of care and quality improvement with over 300 peer reviewed publications. He was made a CBE in the Queen’s Birthday Honours in 2013.

Faye is the National Programme Manager for the Atrial Fibrillation (AF) Programme across the 15 Academic Health Science Networks, she oversees the AF programme across the three programme elements; Detect, Protect and Perfect. This includes the national roll out of AF detection devices, raising public awareness of AF, improving the quality of anticoagulation services and the spread and adoption of best practice in AF nationwide.

Consultant Pharmacist for Cardiovascular Disease, South London, UK
National Clinical Adviser for AF, AHSN Network
Clinical Director for AF, Health Innovation Network
Clinical Lead for Cardiovascular Disease, Southwark and Lambeth CCGs

As Consultant Pharmacist for CVD Disease, Helen is involved in a wide range of activities across South London to improve the care of patients with or at risk of cardiovascular disease (CVD). Helen chairs the local cardiovascular medicines working group which develops and supports the implementation of consensus evidence-based guidance for use across South London’s 12 clinical commissioning groups and 7 acute trusts, covering a population of 3.6million. Currently, there is a strong focus on medicines optimisation in primary care for long terms conditions such as heart failure, hypertension and atrial fibrillation with the aim of reducing the burden of acute hospital admissions and she has been involved in supporting primary care practitioners through guideline implementation, clinical audit and provision of pharmacist-led virtual clinics. A key focus over recent years has been to increase the proportion of patients with AF who are anticoagulated to reduce the incidence of AF-related stroke.

Helen is also the clinical lead for CVD within two South London CCGs, Clinical Director for AF in the local Health Innovation Network, National Clinical Adviser to the collaborative AF programme of the 15 Academic Health Science Networks across England and also co-chair of the Pan-London stroke prevention in Atrial Fibrillation strategy group. In addition, Helen is an editorial board member for the British Journal of Cardiology and the Journal of Medicines Optimisation, has worked with NICE on the development of a number of cardiovascular guidelines and is a member of the NHS England Primary Care Cardiovascular Leadership Forum and the London Cardiovascular and Stroke Strategic Clinical Leadership Groups.

Julia has worked for over 20 years in the public sector and held a number of senior roles that have included working with the NHS, Charity and the academic sector both regionally and nationally. Julia has led a number of national Programmes including with the National Institute for Innovation and Improvement, Healthy Place Healthy Live Programme and NIHR – School for Primary Care Research and Collaboration for Applied Health Research and Care (CLAHRC). Julia obtained her PhD from the University of Liverpool.

Julia’s current role in the Innovation Agency reflects her passion in knowledge mobilisation and putting evidence-based innovation into practice to achieve impact for the benefit of patients. Julia currently leads on spread and adoption programmes in: Atrial Fibrillation and Stroke Prevention, (including personalised medicine; technology such as mobile ECG devices and self-monitoring devices; patient activation and self-management; and digital integration). Julia also has a leading role in the North West Coast Connected Health Cities Programme, which is developing a learning health system for linking data and using it more effectively in care pathways in COPD, Alcohol and Seizures.

Recently retired from full time work after more than thirty years in Higher Education. I was diagnosed with atrial fibrillation (asymptomatic) in 2002 and have been taking warfarin and having regular INR checks since then. Currently I am writing a critical friend report for Cheshire Fire and Rescue Service that examines the addition of atrial fibrillation and affordable warmth checks to their Safe and Well visits to targeted households.

Aidan is a GP by background and has been working as a Consultant in Public Health in Lancashire since 2008. During this time he has held a varied portfolio and more recently has been working on the Cardiovascular Disease agenda and has been instrumental in developing a Lancashire and South Cumbria Stroke Prevention Alliance, which he chairs, along with a range of key partners.

The Stroke Prevention Alliance has recently produced a comprehensive five year Stroke Prevention Strategy which, in line with the successful experience of other countries, has a central focus on the identification and diagnosis of the key risk factors for Stroke of AF, Blood pressure and Cholesterol often referred to as 'Know Your ABCs' as outlined within the recently published NHS Plan. Aidan is passionate about reducing health inequalities and a key measure of success of this strategy will be the degree to which the current scale of inequalities in outcomes can be reduced across the diverse communities which we serve.

Marga is originally from Spain where she completed her BSc in Biology and PhD in Molecular Biology at the University of Santiago de Compostela; part of her PhD work was carried out at the University of Sheffield under the supervision of Prof Ian Peake.

Following a 2 year postdoctoral position at Leeds University, she moved to Liverpool as a Clinical Scientist at the Royal Liverpool and Broadgreen University Hospital, position she held for 13 years. During this period she was promoted to Senior Clinical Scientist, developing new molecular diagnostic tests in the area of coagulation, whilst researching the molecular links of coagulation and sepsis in particular.  She supervised MPhil and PhD students, published a number of manuscripts and presented her research at national and international conferences.

In 2009, she became the R&D manager at the Liverpool Heart and Chest Hospital; she was promoted to Head of Clinical Quality in 2011 and then Head of Research and Innovation in 2013. In 2015 she was offered the opportunity of leading a project, sponsored by Cabinet Office and Department of Health, working directly to the Trust CEO. The outcomes of this had implications in the development of health policy.  In 2016 she became the Assistant Director of Strategy for the Trust, with a main focus on the Cardiovascular Disease Programme in the Cheshire and Merseyside Health and Care Partnership. Her role as Operational Lead for the Programme has given her a system-wide view for innovation and healthcare improvement, with a particular emphasis on prevention.

Marga is an Honorary Lecturer with the University of Liverpool.

The Stroke Prevention Alliance has recently produced a comprehensive five year Stroke Prevention Strategy which, in line with the successful experience of other countries, has a central focus on the identification and diagnosis of the key risk factors for Stroke of AF, Blood pressure and Cholesterol often referred to as 'Know Your ABCs' as outlined within the recently published NHS Plan. Aidan is passionate about reducing health inequalities and a key measure of success of this strategy will be the degree to which the current scale of inequalities in outcomes can be reduced across the diverse communities which we serve.

Nina is an experienced senior NHS manager and qualified accountant who is committed to delivering high quality, innovative and effective services.  She has gained her operational and financial experience across a range of NHS and private sector organisations with a strong track record of delivery, aligned with service transformation and development.

Nina’s most recent posts have been Divisional Director roles within acute providers which has provided her with a true understanding of the operational and financial pressures experienced across health systems and the direct impact on patient care and experience.

Nina is passionate about challenging unwarranted variation across clinical pathways to improve clinical outcomes and create sustainable services. She believes collaborative working across health economies is the key to success.

 

 

 

Jen Kohan is a an educator and instructional specialist with a passion for connected, experiential learning, and design thinking. After twenty years in the American public education system as a teacher, cognitive coach, and equity program coordinator, she currently serves the Innovation Agency as Head of the Coaching Academy.

Jen’s work is grounded in reflective-practice, evidence-based improvement, and collaborative principles. She holds a BA (Hons) in English and an MA (Hons) in Humanities, Qualified Teacher Status, and is trained in intercultural competencies, online learning, cognitive coaching, and implementation science. Jen believes that a coach best serves individuals and teams through guided thinking structures related to specific needs and goals, as determined by participant stakeholders.

Karla is a Project Manager for Improvement and Education in the Transformation Team. Her role is to support the improvement and education offering of the Innovation Agency which includes the development of education materials for stakeholders and management of our communities of practice.

Karla began her NHS career as an apprentice and has since gained over 15 years experience within a community setting mainly within HR and Education Services for the North West region. Karla has been recognised over the years for the work she has achieved with the ‘Talent for Care’ agenda showing real passion to develop staff and others through widening participation and is an awarding winning mentor. Karla has a degree in Fine Art and has also recently completed a PGCE and is passionate about all things visual , you can often find her sketchnoting and showing work on twitter @krimaitis

 

VENUE

Mercure Hotel Haydock 600 410

Mercure Haydock

Penny Lane, Haydock WA11 9SG

Car:
There is free on-site parking for conference guests.

Train:
The nearest train station is NEWTON LE WILLOWS, 4.02km / 2.5 miles away.

EVENT EXHIBITORS

BHF_Logo_Lockup Vertical_BHF_Red_RGB@4x
ecgod-logo Translucent (2) 250 bigger
Inhealthcare-logo-2018_V2_for-web (1)
LumiraDx 250
Medtronic logo blue 250
microlife+watchbp_Logo

FREE REGISTRATION

Registration is free for healthcare professionals within the UK who have a special interest in AF. Please note that spaces are limited and available on a first-come first-served basis.